ACCOUNTS - Final Accounts preparation

ACCOUNTS - Final Accounts preparation


Caseware UK (AP4) 2018.0.196 2018.0.196 2018-10-312018-10-31truetrueThe provison of customer and client feedback services and the development on CustomServe for the management of client feedbackfalse2017-11-01 02822726 2017-11-01 2018-10-31 02822726 2016-11-01 2017-10-31 02822726 2018-10-31 02822726 2017-10-31 02822726 c:Director1 2017-11-01 2018-10-31 02822726 d:Buildings d:LongLeaseholdAssets 2017-11-01 2018-10-31 02822726 d:Buildings d:LongLeaseholdAssets 2018-10-31 02822726 d:Buildings d:LongLeaseholdAssets 2017-10-31 02822726 d:PlantMachinery 2017-11-01 2018-10-31 02822726 d:PlantMachinery 2018-10-31 02822726 d:PlantMachinery 2017-10-31 02822726 d:PlantMachinery d:OwnedOrFreeholdAssets 2017-11-01 2018-10-31 02822726 d:FurnitureFittings 2017-11-01 2018-10-31 02822726 d:FurnitureFittings 2018-10-31 02822726 d:FurnitureFittings 2017-10-31 02822726 d:FurnitureFittings d:OwnedOrFreeholdAssets 2017-11-01 2018-10-31 02822726 d:OwnedOrFreeholdAssets 2017-11-01 2018-10-31 02822726 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2017-11-01 2018-10-31 02822726 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2018-10-31 02822726 d:DevelopmentCostsCapitalisedDevelopmentExpenditure 2017-10-31 02822726 d:ComputerSoftware 2017-11-01 2018-10-31 02822726 d:ComputerSoftware 2018-10-31 02822726 d:ComputerSoftware 2017-10-31 02822726 d:CurrentFinancialInstruments 2018-10-31 02822726 d:CurrentFinancialInstruments 2017-10-31 02822726 d:CurrentFinancialInstruments d:WithinOneYear 2018-10-31 02822726 d:CurrentFinancialInstruments d:WithinOneYear 2017-10-31 02822726 d:ShareCapital 2018-10-31 02822726 d:ShareCapital 2017-10-31 02822726 d:OtherMiscellaneousReserve 2018-10-31 02822726 d:OtherMiscellaneousReserve 2017-10-31 02822726 d:RetainedEarningsAccumulatedLosses 2018-10-31 02822726 d:RetainedEarningsAccumulatedLosses 2017-10-31 02822726 d:OtherDeferredTax 2018-10-31 02822726 d:OtherDeferredTax 2017-10-31 02822726 c:OrdinaryShareClass1 2017-11-01 2018-10-31 02822726 c:OrdinaryShareClass1 2018-10-31 02822726 c:OrdinaryShareClass1 2017-10-31 02822726 c:FRS102 2017-11-01 2018-10-31 02822726 c:AuditExempt-NoAccountantsReport 2017-11-01 2018-10-31 02822726 c:FullAccounts 2017-11-01 2018-10-31 02822726 c:PrivateLimitedCompanyLtd 2017-11-01 2018-10-31 02822726 c:PublicLimitedCompanyPLCNotQuotedOnAnyExchange 2017-11-01 2018-10-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 02822726









ACUIGEN LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 OCTOBER 2018

 
ACUIGEN LIMITED
REGISTERED NUMBER: 02822726

BALANCE SHEET
AS AT 31 OCTOBER 2018

2018
2017
Note
£
£

Fixed assets
  

Intangible assets
 4 
155,942
162,428

Tangible assets
 5 
41,505
36,443

  
197,447
198,871

Current assets
  

Debtors: amounts falling due within one year
 6 
122,626
103,114

Cash at bank and in hand
 7 
61,292
42,003

  
183,918
145,117

Creditors: amounts falling due within one year
 8 
(273,353)
(123,941)

Net current (liabilities)/assets
  
 
 
(89,435)
 
 
21,176

Total assets less current liabilities
  
108,012
220,047

Provisions for liabilities
  

Deferred tax
 9 
(23,470)
(6,924)

  
 
 
(23,470)
 
 
(6,924)

Net assets
  
84,542
213,123


Capital and reserves
  

Called up share capital 
  
100
100

Other reserves
 11 
2
2

Profit and loss account
 11 
84,440
213,021

  
84,542
213,123


Page 1

 
ACUIGEN LIMITED
REGISTERED NUMBER: 02822726
    
BALANCE SHEET (CONTINUED)
AS AT 31 OCTOBER 2018

The Directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006.

The members have not required the Company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006.

The Directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Mr D Jones
Director

Date: 30 July 2019

The notes on pages 3 to 12 form part of these financial statements.

Page 2

 
ACUIGEN LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2018

1.


General information

Acuigen Limited ("the Company") is a private company limited by shares, registered and incorporated in England and Wales. Registered company number 02822726. The address of its registered office is Cranfield Innovation Centre, Cranfield Technology Park, University Way, Cranfield, Bedfordshire, MK43 0BT. 
The principal activity of the Company continues to be the provision of customer and client feedback services and the development of CustomServe for the management of client feedback.
These financial statements have been presented in Pounds Sterling (£), this being the currency of the primary economic environment in which the Company operates. 
Monetary amounts included in these financial statements have been rounded to the nearest £.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the Company's accounting policies.

The following principal accounting policies have been applied:

 
2.2

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is Pounds Sterling (£).

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of Income and Retained Earnings within 'finance income or costs'. All other foreign exchange gains and losses are presented in the Statement of Income and Retained Earnings within 'other operating income'.

Page 3

 
ACUIGEN LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2018

2.Accounting policies (continued)

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to the Statement of Income and Retained Earnings on a straight line basis over the lease term.

 
2.5

Research and development

In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight line basis over their useful economic life of 3 years.

If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.

 
2.6

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in the Statement of Income and Retained Earnings when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

Page 4

 
ACUIGEN LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2018

2.Accounting policies (continued)

 
2.7

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.
The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.
Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the Balance Sheet date, except that:
•     The recognition of deferred tax assets is limited to the extent that it is probable that they will be
      recovered against the reversal of deferred tax liabilities or other future taxable profits; and
•     Any deferred tax balances are reversed if and when all conditions for retaining associated tax
      allowances have been met.
Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the Balance Sheet date.

 
2.8

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

At each reporting date the company assesses whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is determined which is the higher of its fair value less costs to sell and its value in use. An impairment loss is recognised where the carrying amount exceeds the recoverable amount.

All intangible assets are considered to have a finite useful life of 3 years.
The amortisation expense is charged to administrative expenditure within the Statement of Income and Retained Earnings.

Page 5

 
ACUIGEN LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2018

2.Accounting policies (continued)

 
2.9

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

At each reporting date the company assesses whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is determined which is the higher of its fair value less costs to sell and its value in use. An impairment loss is recognised where the carrying amount exceeds the recoverable amount.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Plant and machinary
-
20%
on reducing balance
Fixtures and fittings
-
20%
on reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in the Statement of Income and Retained Earnings.

The depreciation expense is charged to administrative expenditure within the Statement of Income and Retained Earnings.

 
2.10

Debtors

Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.11

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.12

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 6

 
ACUIGEN LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2018

2.Accounting policies (continued)

 
2.13

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in the case of an out-right short-term loan not at market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of Income and Retained Earnings.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the Balance Sheet date.
Financial assets and liabilities are offset and the net amount reported in the Balance Sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.


3.


Employees

The average monthly number of employees, including Directors, during the year was 16 (2017 - 14).

Page 7

 
ACUIGEN LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2018

4.


Intangible assets




Development expenditure
Computer software
Total

£
£
£



Cost


At 1 November 2017
451,432
82,286
533,718


Additions - internal
142,820
9,041
151,861



At 31 October 2018

594,252
91,327
685,579



Amortisation


At 1 November 2017
343,858
27,432
371,290


Charge for the year
155,332
3,014
158,346



At 31 October 2018

499,190
30,446
529,636



Net book value



At 31 October 2018
95,062
60,881
155,943



At 31 October 2017
107,574
54,854
162,428

Page 8

 
ACUIGEN LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2018

5.


Tangible fixed assets





Leasehold property improvements
Fixtures and fittings
Plant and Machinary
Total

£
£
£
£



Cost or valuation


At 1 November 2017
32,988
25,072
304,393
362,453


Additions
-
-
16,581
16,581


Disposals
(32,988)
(24,407)
(213,618)
(271,013)



At 31 October 2018

-
665
107,356
108,021



Depreciation


At 1 November 2017
32,988
24,307
268,715
326,010


Charge for the year on owned assets
-
108
11,411
11,519


Disposals
(32,988)
(24,407)
(213,618)
(271,013)



At 31 October 2018

-
8
66,508
66,516



Net book value



At 31 October 2018
-
657
40,848
41,505



At 31 October 2017
-
765
35,678
36,443


6.


Debtors

2018
2017
£
£


Trade debtors
54,063
52,925

Amounts owed by group undertakings
-
2,100

Tax recoverable
29,675
33,829

Prepayments and accrued income
38,888
14,260

122,626
103,114


Amounts owed by group undertakings are unsecured, interest free and repayable on demand.

Page 9

 
ACUIGEN LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2018

7.


Cash and cash equivalents

2018
2017
£
£

Cash at bank and in hand
61,292
42,003



8.


Creditors: Amounts falling due within one year

2018
2017
£
£

Trade creditors
51,259
26,046

Directors' loan accounts
94,763
68,831

Other taxation and social security
4,027
18,649

Other creditors
13,130
3,127

Accruals and deferred income
110,174
7,288

273,353
123,941


The Company has a £50,000 overdraft facility, secured by a fixed and floating charge over the assets of the Company and a personal guarantee given by the Directors.
The amounts owed to the Director's are unsecured, interest free and repayable on demand.


9.


Deferred taxation




2018


£






At beginning of year
(6,924)


Charged to profit or loss
(16,546)



At end of year
(23,470)

The provision for deferred taxation is made up as follows:

2018
2017
£
£


Fixed asset timing differences
(23,470)
(6,924)

Page 10

 
ACUIGEN LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2018

10.


Share capital

2018
2017
£
£
Allotted, called up and fully paid



100 (2017 - 100) Ordinary shares of £1.00 each
100
100

The Company has one class of ordinary share. Each share carries with it voting rights but have no rights to any fixed income nor do they have any other preference attached to them.



11.


Reserves

Other reserves

The Other reserve relates to the addition of investment in a subsidiary company. 

Profit and loss account

The Profit and loss account reserve represents the cumulative profits and losses of the Company, less dividends paid.


12.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £4,475 (2017 - £4,254).
 
Contributions totalling £514 (2017 - £393) were payable to the fund at the Balance Sheet date and are included in Other creditors.


13.


Related party transactions

Directors' loan accounts
As at the year end the Director, Derek Jones, was owed an amount of £47,381.
As at the year end the Director, Tracy Bartlett, was owed an amount of £47,381.
The amounts due to the Director's are unsecured, interest free and repayable on demand.
Business Vision Holdings Limited
As at the year end the Company was owed £Nil (2017 - £2,100) by Business Vision Holdings Limited, the parent Company.
During the year, the Company wrote-off the amount of £2,100 owed by Business Vision Holdings Limited as this balance related to a historic VAT difference.

Page 11

 
ACUIGEN LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2018

14.


Controlling party

The parent and ultimate holding company is Business Vision Holdings Limited, a company registered in England and Wales (registered number 03407410) with the registered address Cranfield Innovation Centre, Cranfield Technology Park, University Way Cranfield, Bedfordshire, MK43 0BT.
The ultimate controlling parties are considered to be the Director's by virtue of their shareholdings in the ultimate holding company, Business Vision Holdings Limited.

 
Page 12